PANOBINOSTAT |
FARYDAK |
LBH589 |
LBH-589 |
LBH 589 |
FARYDAK® |
(2E)-N-HYDROXY-3-[4-({[2-(2-METHYL-1H-INDOL-3-YL)ETHYL]AMINO}METHYL)PHENYL]ACRYLAMIDE |
pubchem.compound:6918837 |
chemidplus:404950-80-7 |
chembl:CHEMBL483254 |
drugbank:06603 |
rxcui:1603350 |
FDA Approval | Multiple myeloma |
Drug Class | Small molecule inhibitor |
FDA Approval | not approved |
Drug Class | small molecule |
Drug Indications | antineoplastic agent |
Pharmaceutical Developer | Novartis |
Source Reported Drug Name(s) | Panobinostat |
Drug Class | HDAC Inhibitor |
inhibitor (inhibitory) |
Notes | |
Reported Cancer Type | Prostate |
Trial Name | Panobinostat |
inhibitor (inhibitory) |
Trial Name | Panobinostat |
Novel drug target | Established target |
Notes |
inhibitor (inhibitory) |
Notes | |
Trial Name | Panobinostat |
Novel drug target | Established target |
inhibitor (inhibitory) |
Novel drug target | Established target |
Trial Name | Panobinostat |
Notes |
inhibitor (inhibitory) |
Trial Name | Panobinostat |
Novel drug target | Established target |
Notes |
inhibitor (inhibitory) |
Trial Name | Panobinostat |
Novel drug target | Established target |
Notes |
inhibitor (inhibitory) |
Novel drug target | Established target |
Trial Name | Panobinostat |
Notes |
inhibitor (inhibitory) |
Novel drug target | Established target |
Trial Name | Panobinostat |
Notes |
inhibitor (inhibitory) |
Trial Name | Panobinostat |
Novel drug target | Established target |
Notes |
inhibitor (inhibitory) |
Notes | |
Trial Name | Panobinostat |
Novel drug target | Established target |
inhibitor (inhibitory) |
Notes | |
Trial Name | Panobinostat |
Novel drug target | Established target |
FARYDAK | Trade Name |
Drug Class | Small molecule inhibitor |
FDA Approval | Multiple myeloma |
Panobinostat | PubChem Drug Name |
6918837 | PubChem Drug ID |
Panobinostat | Drug Trade Name |
Drug Class | HDAC Inhibitor |
Source Reported Drug Name(s) | Panobinostat |
Pharmaceutical Developer | Novartis |
Drug Indications | antineoplastic agent |
Drug Class | small molecule |
FDA Approval | not approved |
CHEMBL483254 | ChEMBL Drug ID |
PANOBINOSTAT | Primary Drug Name |
PANOBINOSTAT | Drug Generic Name |
FARIDAK | Drug Trade Name |
D0E3SH | TTD Drug ID |